Zhiyun Health, a startup created by Ming Kuang, alumnus of Cambridge Judge Business School (MBA 2010) was officially listed on the Main Board of the Hong Kong Stock Exchange today, with Morgan Stanley and JPMorgan Chase & Co. as joint sponsors, becoming the “first stock of chronic disease management” in Hong Kong stocks with a market value of more than HK$17.3 billion, the article says. (transl. from Chinese)
Read the full article [mp.weixin.qq.com]
Brain food 
Compass 
Entrepreneurship 
In the media 
Network 
News 
Reasons why 
The lowdown 
Thinkers
Comments